N-acetylcystein

DRUG5 trials

Sponsors

Seoul National University Hospital, Azienda Ospedaliera di Padova, Assistance Publique - Hôpitaux de Paris, Tehran University of Medical Sciences, Psychiatric University Hospital, Zurich

Conditions

Acute Myocardial InfarctionCannabis AbuseCannabis DependenceCarcinoma, HepatocellularCocaine AddictionKidney FailureLiver DiseasesLiver Failure

Phase 2

Use of N-Acetylcysteine During Liver Procurement

CompletedNCT01394497

Azienda Ospedaliera di PadovaCarcinoma, Hepatocellular, Liver Diseases, Liver Failure +2

Start: 2006-12-31End: 2009-07-31Updated: 2013-02-18

Clinical Trial of N-acetylcysteine Versus Placebo Efficacy in the Cannabis Withdrawal

TerminatedNCT01439828

Assistance Publique - Hôpitaux de ParisCannabis Abuse, Cannabis Dependence

Start: 2012-02-29End: 2015-02-28Updated: 2021-06-18

Phase 3

Effect of N-acetylcystein in Myocardial Infarction

Tehran University of Medical SciencesAcute Myocardial Infarction

Start: 2011-01-31End: 2012-12-31Target: 100Updated: 2012-12-04

Phase 4

NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization

CompletedNCT00356954

Seoul National University HospitalKidney Failure

Start: 2005-02-28End: 2006-04-30Target: 250Updated: 2006-11-27

Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction

CompletedNCT02626494

Psychiatric University Hospital, ZurichCocaine Addiction

Start: 2015-03-31End: 2017-03-31Updated: 2017-05-01

Related Papers

N-acetylcysteine reduces prefrontal reactivity to cocaine cues in individuals with cocaine use disorder

Frontiers in Psychiatry2025-02-272 citations

Protection from Reperfusion Injury with Intracoronary N-Acetylcysteine in Patients with STEMI Undergoing Primary Percutaneous Coronary Intervention in a Cardiac Tertiary Center.

2018-06-0117 citations